What's breaking now, across thousands of outlets.
(RTTNews) - Bayer (BYR.L, BAY.MI, BAYN.DE) announced the FDA has approved Kerendia or finerenone for the treatment of adult patients with chronic kidney disease associated with type 1 diabetes. The approval represents the third approved indication for Kerendia in the U.S. Fineren
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
BRANDON — A CT-scanner is expected to be operational in Dauphin next week after the city’s hospital closed in early July. The unit, which is being set up on the […]
New research from the CU Anschutz Marcus Institute for Brain Health shows that irritability is strongly associated with post-traumatic stress disorder (PTSD) symptoms, chronic pain and difficulty…
Sanofi and Vietnam Vaccine Joint Stock Company (VNVC) have signed a joint declaration on next-generation vaccine manufacturing in Vietnam, with three vaccines initially selected for assessment as…
Health-e News OP-ED | Men are dying by suicide – Why are so many still suffering in silence? When I started working on an article about men and suicide, I wanted to include the voices of men…
[New Zimbabwe] NURSES say they have been betrayed by the government after it failed to honour an agreement to increase health-specific allowances.
The number of new HIV carriers fell by 38 to 624, the lowest in 20 years, while that of AIDS patients dropped by 66 to 266.
